ANAPTYSBIO INC
For the period ended Mar 31, 2025. Filed May 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 5, 2025
ANAB$46.45+1.9%Stored close · as of Nov 6, 2026
Contents
Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024
Consolidated Balance Sheets
(in thousands, except par value data)
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $98,637 | $123,080 |
| Receivables from collaborative partners | 17,884 | 40,765 |
| Short-term investments | 241,299 | 262,293 |
| Prepaid expenses and other current assets | 5,292 | 5,738 |
| Total current assets | 363,112 | 431,876 |
| Property and equipment, net | 1,741 | 1,849 |
| Operating lease right-of-use assets | 13,923 | 14,383 |
| Long-term investments | 43,021 | 35,470 |
| Other long-term assets | 256 | 256 |
| Total assets | $422,053 | $483,834 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $6,123 | $4,002 |
| Accrued expenses | 35,952 | 39,501 |
| Current portion of operating lease liability | 1,962 | 1,925 |
| Total current liabilities | 44,037 | 45,428 |
| Liability related to sale of future royalties | 330,382 | 353,426 |
| Operating lease liability, net of current portion | 13,613 | 14,112 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000 shares authorized and no shares, issued or outstanding at March 31, 2025 and December 31, 2024, respectively | — | — |
| Common stock, $0.001 par value, 500,000 shares authorized, 30,388 shares and 30,473 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 30 | 30 |
| Additional paid in capital | 832,486 | 829,860 |
| Accumulated other comprehensive gain | 161 | 305 |
| Accumulated deficit | (798,656) | (759,327) |
| Total stockholders’ equity | 34,021 | 70,868 |
| Total liabilities and stockholders’ equity | $422,053 | $483,834 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.